from journal PLOS ONE
People being treated for certain cancers
may want to talk to their doctor about
taking low-dose aspirin in addition to their
cancer treatment. Doing so may increase
their chance of survival by up to twenty
percent and help stop their cancer from
spreading. Authors of a review of
scientific literature published in the journal
PLOS ONE acknowledge low-dose aspirin
has been shown to reduce the incidence of
cancer, but this review of nearly fifty
studies of bowel, breast and prostate
cancers suggests aspirin, in addition to
other treatments, is associated with
reducing deaths by fifteen to twenty
percent. The authors suggest
conversations between patients and
doctors about whether to make low-dose
aspirin part of their treatment.